API Manufacturing
Our Manufacturing Sites & Facilities
Three state-of-the-art cGMP manufacturing sites equipped with advanced reaction platforms, ISO 8 clean rooms, and comprehensive analytical laboratories.
Norac Pharma
US FDA and DEA registered facility specialized in custom synthesis, small-to-mid scale API production, high potency active ingredients, and US customer process support.
Mandva Facility
Large scale US FDA, WHO-GMP inspected site featuring dedicated peptide manufacturing, continuous flow systems, biocatalysis development, and bulk commercial APIs.
Ankleshwar Facility
High capacity US FDA, MFDS, TGA inspected facility with multi-purpose reaction suites (1KL to 10KL), Hastelloy reactors, ANFDs, and zero liquid discharge systems.
Alkem Activa At A Glance
World-class API manufacturing, sustainable process engineering, and end-to-end CDMO solutions serving pharmaceutical innovators worldwide.
Manufacturing Capabilities
500 KL+ reaction volume across two USFDA approved manufacturing facilities in India and one in California.
Comprehensive End to End Solutions
Custom pharma CDMO solutions help global pharma to overcome development hurdles and accelerate your therapeutic to commercial success.
Sustainability Commitment
Environmentally compliant processes aligned with ESG objectives to support sustainable development and commercial success.
Cutting-Edge Technologies
Strong focus on green technologies with dedicated teams for continuous manufacturing & Biocatalysis.
50+ Active USDMF/ASMFs
Strong global regulatory footprint. 4 CEPs approved and 5 CEPs under filing. Extensive regulatory experience across US, EU, Brazil, South Korea, and other global agencies.
.png)
US FDA.png)
WHO-GMP.png)
식품의약품안전처 (MFDS Korea)
U.S. DEA Compliant
Sustainable
- Focus on advanced manufacturing technologies with dedicated teams for continuous manufacturing and biocatalysis
- Green Chemistry has been emphasized at the development stage of API itself
- Endeavoring high OTIF levels
- API portfolio selection independent of captive formulation portfolio requirements
- Resilient supply chain with majority of KSM sourced locally or back warded integrated
- Zero liquid discharge in operation across our facilities
- Greater emphasize on ESG initiatives
- Extensive use of renewable energy sources